NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Free Cash Flow of -$14.6 million for Q4 2025, down 33.77% year-on-year from -$22.0 million in Q4 2024, and down 893.69% on a QoQ basis from $1.8 million in Q3 2025.
NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Free Cash Flow for 4 consecutive years, with -$14.6 million the latest figure, recorded in Q4 2025.
- Quarterly Free Cash Flow fell 33.77% year-over-year to -$14.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.8 million (down 412.74% YoY) and the FY2025 annual result came in at -$20.6 million, up 60.87% from the prior year.
- Free Cash Flow slipped to -$14.6 million in Q4 2025 per NBP's latest filing, from $1.8 million in the prior quarter.
- Over the last five years, Free Cash Flow for NBP reached as high as $8.4 million in Q3 2024 and fell as low as -$14.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -14.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.60 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Dec 31, 2024 | -10.91 Mn |
| Dec 31, 2024 | -10.91 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Dec 31, 2020 | 151.41 Mn |
| Dec 31, 2020 | 151.41 Mn |
| Sep 30, 2020 | 668,359.95 |
| Sep 30, 2020 | 668,359.95 |
| Dec 31, 2019 | -33.04 Mn |
| Dec 31, 2019 | -33.04 Mn |